Who owns Merrimack Pharma Inc?
- CUSIP Number: 590328209
Tip: Access positions for across all investors
Analyze quarterly positions in Merrimack Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Merrimack Pharma stock
Who bought or sold Merrimack Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| JBF Capital | 40k | $1.2k | 100% | Jun 2024 |
|
| Goldman Sachs Group | 30k | $451k | 106% | Jun 2024 |
|
| Rise Advisors | 272.00 | $0 | 0% | Sep 2024 |
|
| Farther Finance Advisors | 77.00 | $0 | 0% | Sep 2024 |
|
Who sold out of Merrimack Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Mar 2024 | 723k | $11M |
| Vanguard Group | Mar 2024 | 621k | $9.2M |
| Dimensional Fund Advisors | Jun 2024 | 319k | $4.8M |
| Sepio Capital | Mar 2024 | 299k | $4.4M |
| State Street Corporation | Mar 2024 | 247k | $3.6M |
| Northern Trust | Mar 2024 | 118k | $1.7M |
| Morgan Stanley | Mar 2024 | 39k | $583k |
| Marshall Wace | Jun 2024 | 38k | $1.1k |
| Bridgeway Capital Management | Mar 2024 | 34k | $505k |
| Two Sigma Investments | Mar 2024 | 20k | $301k |
| Nuveen Asset Management | Mar 2024 | 14k | $203k |
| Martingale Asset Management | Mar 2024 | 11k | $155k |
| Caldwell Sutter Capital | Jun 2024 | 7.5k | $0 |
| Rhumbline Advisers | Jun 2024 | 2.5k | $38k |
| Goss Wealth Management | Mar 2024 | 1.4k | $21k |
| Russell Investments | Mar 2024 | 1.1k | $16k |
| Tower Research Capital | Mar 2024 | 280.00 | $4.1k |
| Cornerstone Planning Group | Mar 2024 | 231.00 | $3.5k |
| Covestor | Jun 2024 | 106.00 | $0 |